NCT00104455 Dose Response to Recombinant Factor VIIa When Administered for Bleed Status COMPLETED Phase PHASE1
NCT00104182 Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00102817 Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children Status COMPLETED Phase PHASE3
NCT00101751 INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study Status COMPLETED Phase PHASE4
NCT00097877 Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00097279 Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00097084 Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00097071 Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents Status COMPLETED Phase PHASE3
NCT00095446 NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00095082 Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT00071448 Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population Status COMPLETED Phase PHASE3
NCT00065130 Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes Status COMPLETED Phase PHASE3
NCT00056589 Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency Status COMPLETED Phase PHASE1